title: The introduction of new vaccines into developing countries. V: Will we lose a decade or more in the introduction of dengue vaccines to developing countries?
abstract: Dengue results in as many as 390 million infections annually and causes significant morbidity. A number of efforts are underway to develop vaccines against dengue. The public sector is undertaking efforts to create an enabling environment for vaccine introduction. Recent work by Brooks et al. provides a framework for analyzing which efforts should be undertaken before licensure. They conclude that actions before licensure are required to eliminate the decade or more it normally takes to introduce new vaccines into developing countries. We apply their methodology to dengue and identify a number of critical areas where public sector actions before licensure can greatly accelerate vaccine uptake.
authors.affiliation: Global Health Consultant, Sedona, AZ 86336, United States. Electronic address: richardtmahoney@gmail.com.
authors.forename: Richard
authors.initials: R
authors.lastname: Mahoney
mesh_terms: D003715:Dengue / Q000517:prevention & control; D053059:Dengue Vaccines; D003906:Developing Countries; D006291:Health Policy; D017589:Immunization Programs; D008004:Licensure; D017150:Public Sector
chemical_list: D053059:Dengue Vaccines
keywords: Dengue; Introduction; Prelicensure; Vaccines